US Radio Pharmaceutical Market

ID: MRFR/MED/16501-HCR
200 Pages
Nidhi Mandole
Last Updated: April 06, 2026
US Radiopharmaceuticals Market Research Report: Size, Share, Trend Analysis By Types (Diagnostic, Therapeutic) and By Applications (Neurology, Cardiology, Oncology, Others) - Growth Outlook & Industry Forecast 2025 To 2035
US Radio Pharmaceutical Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)9.33%
2024 Market Size$ 1,500 Million
2025 Market Size$ 1,639.95 Million
2035 Market Size$ 4,000 Million
Key Players
GE Healthcare
Siemens Healthineers
Bayer AG
Cardinal Health
Elekta AB
Lantheus Medical Imaging
Trends
  • Technological Advancements
  • Regulatory Support
  • Personalized Medicine
Opportunities
  • Rising Awareness of Nuclear Medicine
  • Expansion of Cancer Treatment Options
  • Increasing Demand for Diagnostic Imaging
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Application (USD Million)
      1. 4.1.1 Diagnosis
      2. 4.1.2 Therapy
      3. 4.1.3 Research
    2. 4.2 Construction, BY Type (USD Million)
      1. 4.2.1 Diagnostic Radiopharmaceuticals
      2. 4.2.2 Therapeutic Radiopharmaceuticals
    3. 4.3 Construction, BY Radiopharmaceutical Class (USD Million)
      1. 4.3.1 Radioisotopes
      2. 4.3.2 Radiolabeled Compounds
      3. 4.3.3 Radiopharmaceutical Generators
    4. 4.4 Construction, BY End Use (USD Million)
      1. 4.4.1 Hospitals
      2. 4.4.2 Diagnostic Imaging Centers
      3. 4.4.3 Research Institutions
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 GE Healthcare (GB)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Siemens Healthineers (DE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Bayer AG (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Cardinal Health (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Elekta AB (SE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Lantheus Medical Imaging (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 NorthStar Medical Radioisotopes (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Radiopharm Theranostics (AU)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Telix Pharmaceuticals (AU)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY APPLICATION
    3. 6.3 US MARKET ANALYSIS BY TYPE
    4. 6.4 US MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
    5. 6.5 US MARKET ANALYSIS BY END USE
    6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CONSTRUCTION
    9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
    12. 6.12 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
    15. 6.15 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 CONSTRUCTION, BY RADIOPHARMACEUTICAL CLASS, 2024 (% SHARE)
    17. 6.17 CONSTRUCTION, BY RADIOPHARMACEUTICAL CLASS, 2024 TO 2035 (USD Million)
    18. 6.18 CONSTRUCTION, BY END USE, 2024 (% SHARE)
    19. 6.19 CONSTRUCTION, BY END USE, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY RADIOPHARMACEUTICAL CLASS, 2025-2035 (USD Million)
      4. 7.2.4 BY END USE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Radio Pharmaceutical Market Segmentation

US Radio Pharmaceutical Market By Application (USD Million, 2025-2035)

  • Diagnosis
  • Therapy
  • Research

US Radio Pharmaceutical Market By Type (USD Million, 2025-2035)

  • Diagnostic Radiopharmaceuticals
  • Therapeutic Radiopharmaceuticals

US Radio Pharmaceutical Market By Radiopharmaceutical Class (USD Million, 2025-2035)

  • Radioisotopes
  • Radiolabeled Compounds
  • Radiopharmaceutical Generators

US Radio Pharmaceutical Market By End Use (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Imaging Centers
  • Research Institutions

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.